PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival

D. Planchard, P.A. Jänne, K. Kobayashi, J.C.-H. Yang, Y. Liu, Natalia Valdiviezo, T.M. Kim, Lingxiang Jiang, H. Kagamu, N. Yanagitani, J. Wang, Bivas Biswas, Artem Poltoratskiy, Yeni Nerón, Celeste Rojas, Leona Koubková, Carles Escriu, Doreen A. Ezeife, K. Barrett, Muna Albayaty, Haiyi Jiang, Chee Khoon Lee